Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Akebia Therapeutics, Inc. (AKBA)
USD1.39
+0.01 (+1.07%)
US NASDAQ Healthcare Biotechnology
Address
245 First Street 2142
Cambridge, MA, US
Cambridge, MA, US
CEO
John Butler
Website
akebia.com
IPO
2014-03-20
CIK 1517022 ISIN US00972D1054
Description
Akebia Therapeutics, Inc., established in 2007 and headquartered in Cambridge, Massachusetts, is a biopharmaceutical company focused on discovering and commercializing therapies for patients suffering from kidney diseases. The firm's leading experimental drug, vadadustat, is an oral treatment currently in Phase III clinical trials. Its purpose is to address anemia resulting from chronic kidney disease (CKD) in adult patients, encompassing both those dependent on dialysis and those who are not. Akebia also markets Auryxia, a ferric citrate product used to manage serum phosphorus levels in adult CKD patients undergoing dialysis, and to treat iron deficiency anemia in adult CKD patients who are not on dialysis. The company has several key collaboration agreements: with Otsuka Pharmaceutical Co. Ltd. for vadadustat's development and commercialization across major regions including the United States, European Union, Russia, China, Australia, Canada, and the Middle East; with Mitsubishi Tanabe Pharma Corporation for vadadustat in Japan and other Asian territories; and a research and licensing deal with Janssen Pharmaceutica NV pertaining to hypoxia-inducible factor prolyl hydroxylase targeted compounds globally.
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Keryx Biopharmaceuticals, Inc. | KERX | 2018-10-01 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD1.39
+0.01 (+1.07%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
5M
Beta
0.25
Float Shares
262.21M
Free Float %
97.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.86% | +0.88% | -17.86% | -15.44% | -37.84% | -28.57% | -52.67% | +1.77% | -65.05% | -85.08% | -95.69% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (11 ratings, all time)
Buy
Price Targets & DCF
Current price
1.39
Low
4.00
+186.8%
Consensus
4.00
+186.8%
Median
4.00
+186.8%
High
4.00
+186.8%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 1 | 0 |
| Buy | 4 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 1 |
4.00
+186.8%
|
| All Time | 3 |
5.67
+306.5%
|
Quality scores
Altman Z-Score
-5.08
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
D+
Overall Score
1 / 5
Low
DCF Score
1 / 5
Low
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
2 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+47.5% ★ Q1'26: -6.6% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+93.7% ★ Q1'26: -234.0% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%+5.1% Q1'26: -39.6% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%+8.7% ★ Q1'26: -8.8% (vs Q1'25)
-
ROIC Biotechnology: -16.1%+31.9% ★ Q1'26: +15.3% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+21.9% Q1'26: +10.5% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×9.96× Q1'26: -0.72× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 3 Rev. Ana. 3 EPS Ana. |
Dec 2027 4 Rev. Ana. 3 EPS Ana. |
Dec 2028 4 Rev. Ana. 4 EPS Ana. |
Dec 2029 3 Rev. Ana. 2 EPS Ana. |
Dec 2030 3 Rev. Ana. 2 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 24.50M (-100.0%)
|
1.54M
est: 125.00M (-98.8%)
|
177.98M
est: 133.81M (+33.0%)
|
207.74M
est: 216.93M (-4.2%)
|
335.00M
est: 358.54M (-6.6%)
|
294.64M
est: 288.48M (+2.1%)
|
211.65M
est: 205.76M (+2.9%)
|
292.48M
est: 284.82M (+2.7%)
|
194.62M
est: 174.50M (+11.5%)
|
160.18M
est: 151.04M (+6.1%)
|
236.20M
est: 229.24M (+3.0%)
|
217.59M
207.75M – 234.76M
-5.1% YoY
|
165.37M
164.50M – 166.85M
-24.0% YoY
|
202.54M
187.51M – 215.20M
+22.5% YoY
|
222.61M
206.09M – 236.52M
+9.9% YoY
|
263.03M
243.52M – 279.48M
+18.2% YoY
|
| EBITDA |
-61.42M
est: -7.30M (-741.5%)
|
-136.16M
est: -37.24M (-265.7%)
|
-76.06M
est: -39.86M (-90.8%)
|
-178.09M
est: -64.62M (-175.6%)
|
-249.87M
est: -106.81M (-133.9%)
|
-139.83M
est: -234.44M (+40.4%)
|
-189.91M
est: -61.30M (-209.8%)
|
3.06M
est: -24.42M (+112.5%)
|
-8.27M
est: -32.21M (+74.3%)
|
-13.72M
est: -27.88M (+50.8%)
|
21.73M
est: -42.32M (+151.3%)
|
-40.17M
-43.34M – -38.35M
+5.1% YoY
|
-30.53M
-30.80M – -30.37M
+24.0% YoY
|
-37.39M
-39.73M – -34.61M
-22.5% YoY
|
-41.09M
-43.66M – -38.04M
-9.9% YoY
|
-48.55M
-51.59M – -44.95M
-18.2% YoY
|
| EBIT |
-61.51M
est: -11.11M (-453.9%)
|
-136.46M
est: -56.66M (-140.8%)
|
-76.67M
est: -60.65M (-26.4%)
|
-178.16M
est: -98.33M (-81.2%)
|
-286.29M
est: -162.51M (-76.2%)
|
-174.52M
est: -257.55M (+32.2%)
|
-227.88M
est: -93.26M (-144.3%)
|
-34.64M
est: -71.00M (+51.2%)
|
-45.89M
est: -55.40M (+17.2%)
|
-51.23M
est: -47.95M (-6.8%)
|
20.46M
est: -72.78M (+128.1%)
|
-69.08M
-74.53M – -65.96M
+5.1% YoY
|
-52.50M
-52.97M – -52.23M
+24.0% YoY
|
-64.30M
-68.32M – -59.53M
-22.5% YoY
|
-70.68M
-75.09M – -65.43M
-9.9% YoY
|
-83.51M
-88.73M – -77.31M
-18.2% YoY
|
| Net Income |
-60.72M
est: -406.20M (+85.1%)
|
-135.75M
est: -779.20M (+82.6%)
|
-76.91M
est: -545.04M (+85.9%)
|
-171.90M
est: -423.21M (+59.4%)
|
-279.66M
est: -437.36M (+36.1%)
|
-384.84M
est: -262.59M (-46.6%)
|
-282.02M
est: -345.25M (+18.3%)
|
-94.23M
est: -98.22M (+4.1%)
|
-51.93M
est: -52.06M (+0.3%)
|
-69.41M
est: -78.57M (+11.7%)
|
-5.35M
est: -817.8K (-553.6%)
|
-15.52M
-115.21M – 76.81M
-1,797.3% YoY
|
-50.64M
-93.43M – -18.69M
-226.4% YoY
|
6.44M
-237.87M – 178.40M
+112.7% YoY
|
-11.57M
-12.51M – -10.46M
-279.7% YoY
|
1.71M
1.55M – 1.85M
+114.8% YoY
|
| SGA |
18.50M
est: 14.70M (+25.8%)
|
22.21M
est: 75.00M (-70.4%)
|
27.01M
est: 80.28M (-66.4%)
|
87.06M
est: 130.15M (-33.1%)
|
149.46M
est: 215.11M (-30.5%)
|
154.10M
est: 114.38M (+34.7%)
|
174.14M
est: 123.45M (+41.1%)
|
138.60M
est: 190.34M (-27.2%)
|
100.23M
est: 102.32M (-2.0%)
|
106.55M
est: 88.56M (+20.3%)
|
107.48M
est: 134.42M (-20.0%)
|
127.59M
121.82M – 137.66M
-5.1% YoY
|
96.97M
96.46M – 97.84M
-24.0% YoY
|
118.76M
109.95M – 126.19M
+22.5% YoY
|
130.53M
120.85M – 138.69M
+9.9% YoY
|
154.24M
142.79M – 163.88M
+18.2% YoY
|
| EPS |
-2.29
est: -1.93 (-18.9%)
|
-3.60
est: -3.69 (+2.5%)
|
-1.77
est: -2.58 (+31.5%)
|
-1.47
est: -2.01 (+26.7%)
|
-2.36
est: -2.07 (-13.8%)
|
-2.53
est: -2.54 (+0.3%)
|
-1.48
est: -1.64 (+9.6%)
|
-0.58
est: -0.64 (+9.4%)
|
-0.28
est: -0.20 (-37.2%)
|
-0.33
est: -0.31 (-8.0%)
|
-0.02
est: 0.00 (-754.1%)
|
-0.11
-0.45 – 0.30
-3,622.0% YoY
|
-0.22
-0.36 – -0.07
-94.6% YoY
|
-0.09
-0.93 – 0.69
+57.6% YoY
|
-0.05
-0.05 – -0.04
+51.4% YoY
|
0.01
0.01 – 0.01
+114.8% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 2/5 | 1/5 | 1/5 |
| 2026-05-06 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-15 | D+ | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
64.86M
OE per share TTM
0.24
Owner's Yield
20.58%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
10.2%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
45
Total invested
4.86M
Insider transactions (90d)
0
Beneficial owners (>5%)
18
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | STATE STREET CORPORATION | 22.48M | 15.55% | — | — | — | 22.48M | HC | — | 2021-02-11 | ↗ |
| 2 | SSGA FUNDS MANAGEMENT, INC. | 19.93M | 13.79% | — | — | — | 19.93M | IA | — | 2021-02-11 | ↗ |
| 3 | The Baupost Group L.L.C.04-3402144 | 17.53M | 13.50% | — | 17.53M | — | 17.53M | IA | United States America | 2020-04-09 | ↗ |
| 4 | (1) BlackRock, Inc. | 15.20M | 7.20% | 14.97M | — | — | — | HC | Delaware | 2024-11-08 | ↗ |
| 5 | Muneer A. Satter | 13.86M | 7.50% | 13.86M | — | 13.86M | — | IN | United States of America | 2022-12-19 | ↗ |
| 6 | The Vanguard Group - 23-1945930 | 13.24M | 7.56% | — | 210.4K | 12.90M | 336.3K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 7 | Wellington Management Company LLP | 11.82M | 8.18% | — | 11.61M | — | — | IA | Massachusetts | 2021-02-03 | ↗ |
| 8 | Daniel Mack | 7.04M | 4.90% | — | 7.04M | — | — | HC | USA | 2021-02-12 | ↗ |
| 9 | Wilmot B. Harkey | 7.04M | 4.90% | — | 7.04M | — | — | HC | USA | 2021-02-12 | ↗ |
| 10 | Nantahala Capital Management, LLC | 6.74M | 5.70% | — | 6.74M | — | — | IA | MA | 2020-02-13 | ↗ |
| 11 | (1)Names of reporting persons. BlackRock, Inc. | 4.34M | 2.40% | 4.28M | — | 4.34M | — | HC | Delaware | 2022-07-08 | ↗ |
| 12 | Wellington Group Holdings LLP | 711.00 | 0.00% | — | 711.00 | — | — | HC | Massachusetts | 2021-08-10 | ↗ |
| 13 | Wellington Investment Advisors Holdings LLP | 711.00 | 0.00% | — | 711.00 | — | — | HC | Massachusetts | 2021-08-10 | ↗ |
| 14 | Wellington Management Group LLP | 711.00 | 0.00% | — | 711.00 | — | — | HC | Massachusetts | 2021-08-10 | ↗ |
| 15 | Abrams Capital Management, L.P. | 10.00 | 12.00% | — | — | — | — | OO | Abrams Capital Partners II LP Delaware Abrams Capital LLC Delaware Abrams Capital Management LLC Delaware Abrams Capital Management LP Delaware David Abrams United States | 2019-02-14 | ↗ |
| 16 | Baupost Group GP, L.L.C.82-3254604 | — | 0.00% | — | — | — | — | HC | Delaware | 2020-10-09 | ↗ |
| 17 | Seth A. Klarman | — | 0.00% | — | — | — | — | HC | Delaware | 2020-10-09 | ↗ |
| 18 | The Baupost Group, L.L.C.04-3402144 | — | 0.00% | — | — | — | — | IA | Delaware | 2020-10-09 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
45
-129 vs prev Q
New positions
11
Closed positions
135
Increased
17
Reduced
9
Put/Call ratio
0.00
Calls held
—
Puts held
6.0K
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 299.8K +299.0K (+39,976.3%) | 34.09M +34.1M (+1,669,342.1%) | 0.11% +0.113 pp | 0.02% +0.021 pp | USD1.61 +0.0% | 4 qtrs — |
| 2 | BLACKROCK, INC. | 19.32M +521.4K (+2.8%) | 31.10M -20.2M (-39.4%) | 7.30% +0.137 pp | 0.00% 0.000 pp | USD1.73 -6.9% | 6 qtrs — |
| 3 | VANGUARD GROUP INC | 16.02M +468.9K (+3.0%) | 25.79M -16.7M (-39.2%) | 6.05% +0.127 pp | 0.00% 0.000 pp | USD3.40 -52.6% | 47 qtrs — |
| 4 | STATE STREET CORP | 13.69M +1.8M (+15.6%) | 22.04M -10.3M (-31.9%) | 5.17% +0.658 pp | 0.00% 0.000 pp | USD2.14 -24.8% | 47 qtrs — |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 6.28M +92.2K (+1.5%) | 10.11M -6.8M (-40.1%) | 2.37% +0.015 pp | 0.00% -0.001 pp | USD3.10 -48.1% | 47 qtrs — |
| 6 | GOLDMAN SACHS GROUP INC | 4.71M +2.9M (+166.2%) | 7.58M +2.8M (+57.0%) | 1.78% +1.104 pp | 0.00% +0.000 pp | USD1.91 -15.7% | 43 qtrs — |
| 7 | CITADEL ADVISORS LLC | 4.67M +1.5M (+46.4%) | 7.51M -1.2M (-13.6%) | 1.76% +0.549 pp | 0.00% 0.000 pp | USD1.97 -18.3% | 32 qtrs — |
| 8 | RENAISSANCE TECHNOLOGIES LLC | 3.59M -359.6K (-9.1%) | 5.78M -5.0M (-46.4%) | 1.36% -0.148 pp | 0.01% -0.005 pp | USD1.25 +28.8% | 26 qtrs — |
| 9 | QUBE RESEARCH & TECHNOLOGIES LTD | 2.99M -215.4K (-6.7%) | 4.82M -3.9M (-45.0%) | 1.13% -0.092 pp | 0.00% -0.004 pp | USD2.53 -36.4% | 15 qtrs — |
| 10 | CITIGROUP INC | 2.44M +519.5K (+27.1%) | 3.92M -1.3M (-25.0%) | 0.92% +0.190 pp | 0.00% -0.001 pp | USD2.43 -33.7% | 47 qtrs — |
| 11 | NORTHERN TRUST CORP | 2.31M -173.3K (-7.0%) | 3.72M -3.1M (-45.1%) | 0.87% -0.073 pp | 0.00% 0.000 pp | USD2.81 -42.7% | 47 qtrs — |
| 12 | BANK OF AMERICA CORP /DE/ | 2.26M +468.9K (+26.2%) | 3.63M -1.2M (-25.6%) | 0.85% +0.171 pp | 0.00% 0.000 pp | USD2.54 -36.6% | 46 qtrs — |
| 13 | ACADIAN ASSET MANAGEMENT LLC | 2.20M +51.8K (+2.4%) | 3.54M -2.3M (-39.6%) | 0.83% +0.013 pp | 0.01% -0.004 pp | USD3.26 -50.6% | 3 qtrs — |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 2.18M +10.5K (+0.5%) | 3.51M -2.4M (-40.7%) | 0.82% -0.003 pp | 0.00% 0.000 pp | USD2.28 -29.4% | 47 qtrs — |
| 15 | NANTAHALA CAPITAL MANAGEMENT, LLC | 2.00M +— (+0.0%) | 3.22M -2.2M (-41.0%) | 0.76% -0.006 pp | 0.11% -0.083 pp | USD1.92 -16.1% | 4 qtrs — |
| 16 | MILLENNIUM MANAGEMENT LLC | 1.65M -1.2M (-42.1%) | 2.66M -5.1M (-65.9%) | 0.62% -0.464 pp | 0.00% -0.002 pp | USD2.69 -40.1% | 46 qtrs — |
| 17 | HRT FINANCIAL LP | 1.62M +1.6M (+6,430.4%) | 2.61M +2.5M (+3,791.0%) | 0.61% +0.602 pp | 0.01% +0.008 pp | USD1.63 -1.2% | 4 qtrs — |
| 18 | DIMENSIONAL FUND ADVISORS LP | 1.57M -195.7K (-11.1%) | 2.53M -2.3M (-47.6%) | 0.59% -0.080 pp | 0.00% -0.001 pp | USD2.66 -39.5% | 5 qtrs — |
| 19 | FEDERATED HERMES, INC. | 1.29M +651.8K (+101.9%) | 2.08M +333.3K (+19.1%) | 0.49% +0.244 pp | 0.00% +0.000 pp | USD2.59 -37.8% | 23 qtrs — |
| 20 | MORGAN STANLEY | 1.23M -3.1M (-71.5%) | 1.98M -9.8M (-83.2%) | 0.46% -1.179 pp | 0.00% -0.001 pp | USD2.70 -40.4% | 47 qtrs — |
| 21 | SQUAREPOINT OPS LLC | 1.22M +444.5K (+57.1%) | 1.97M -156.3K (-7.4%) | 0.46% +0.165 pp | 0.00% +0.000 pp | USD2.38 -32.4% | 9 qtrs — |
| 22 | FMR LLC | 1.13M +213.8K (+23.4%) | 1.81M -677.0K (-27.2%) | 0.43% +0.078 pp | 0.00% +0.000 pp | USD1.24 +29.8% | 16 qtrs — |
| 23 | FIRST TRUST ADVISORS LP | 941.7K +941.7K (+100.0%) | 1.52M +1.5M (+100.0%) | 0.36% +0.356 pp | 0.00% +0.001 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 24 | BARCLAYS PLC | 923.5K +650.4K (+238.2%) | 1.49M +1.1M (+312.5%) | 0.35% +0.245 pp | 0.00% +0.000 pp | USD2.02 -20.3% | 8 qtrs — |
| 25 | UBS GROUP AG | 871.5K -2.8M (-76.1%) | 1.40M -8.6M (-85.9%) | 0.33% -1.060 pp | 0.00% -0.001 pp | USD2.58 -37.6% | 45 qtrs — |
| 26 | WELLINGTON MANAGEMENT GROUP LLP | 786.5K -83.3K (-9.6%) | 1.27M -1.1M (-46.7%) | 0.30% -0.034 pp | 0.00% 0.000 pp | USD1.86 -13.4% | 6 qtrs — |
| 27 | NORDEA INVESTMENT MANAGEMENT AB | 752.1K +752.1K (+100.0%) | 1.21M +1.2M (+100.0%) | 0.28% +0.284 pp | 0.00% +0.001 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 28 | CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 753.9K -266.8K (-26.1%) | 1.21M -1.6M (-56.4%) | 0.28% -0.104 pp | 0.00% -0.006 pp | USD1.64 -1.8% | 20 qtrs — |
| 29 | BNP PARIBAS ARBITRAGE, SNC | 730.4K -128.1K (-14.9%) | 1.18M -1.2M (-49.8%) | 0.28% -0.051 pp | 0.00% -0.001 pp | USD3.16 -49.1% | 46 qtrs — |
| 30 | JANUS HENDERSON GROUP PLC | 704.0K +588.7K (+510.7%) | 1.13M +817.6K (+259.3%) | 0.27% +0.222 pp | 0.00% +0.000 pp | USD1.79 -10.1% | 2 qtrs — |
| 31 | JANE STREET GROUP, LLC | 691.6K +540.8K (+358.7%) | 1.11M +701.8K (+170.5%) | 0.26% +0.204 pp | 0.00% +0.000 pp | USD1.85 -13.0% | 29 qtrs — |
| 32 | INVESCO LTD. | 669.2K -1.7M (-72.1%) | 1.08M -5.5M (-83.6%) | 0.25% -0.662 pp | 0.00% -0.001 pp | USD2.64 -39.0% | 24 qtrs — |
| 33 | BANK OF NEW YORK MELLON CORP | 666.9K -12.3K (-1.8%) | 1.07M -780.6K (-42.1%) | 0.25% -0.007 pp | 0.00% 0.000 pp | USD1.80 -10.6% | 47 qtrs — |
| 34 | JACOBS LEVY EQUITY MANAGEMENT, INC | 657.8K -4.7K (-0.7%) | 1.06M -749.6K (-41.4%) | 0.25% -0.004 pp | 0.00% -0.003 pp | USD1.45 +11.0% | 35 qtrs — |
| 35 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 647.7K +155.4K (+31.6%) | 1.04M -301.3K (-22.4%) | 0.24% +0.057 pp | 0.00% +0.000 pp | USD1.93 -16.6% | 31 qtrs — |
| 36 | AQR CAPITAL MANAGEMENT LLC | 646.7K +204.2K (+46.2%) | 1.04M -166.8K (-13.8%) | 0.24% +0.076 pp | 0.00% 0.000 pp | USD2.37 -32.1% | 6 qtrs — |
| 37 | NUVEEN, LLC | 593.0K -1.7M (-74.2%) | 954.7K -5.3M (-84.8%) | 0.22% -0.653 pp | 0.00% -0.001 pp | USD3.42 -52.9% | 4 qtrs — |
| 38 | HENNION & WALSH ASSET MANAGEMENT, INC. | 499.0K +499.0K (+100.0%) | 803.3K +803.3K (+100.0%) | 0.19% +0.188 pp | 0.03% +0.028 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 39 | RAFFERTY ASSET MANAGEMENT, LLC | 498.6K +16.8K (+3.5%) | 802.8K -512.7K (-39.0%) | 0.19% +0.005 pp | 0.00% -0.002 pp | USD2.44 -34.0% | 5 qtrs — |
| 40 | SWISS NATIONAL BANK | 496.7K -12.6K (-2.5%) | 799.7K -590.7K (-42.5%) | 0.19% -0.006 pp | 0.00% 0.000 pp | USD2.73 -41.0% | 2 qtrs — |
| 41 | XTX TOPCO LTD | 472.5K +434.3K (+1,136.8%) | 760.7K +656.4K (+629.4%) | 0.18% +0.164 pp | 0.02% +0.015 pp | USD1.73 -6.9% | 6 qtrs — |
| 42 | AMERICAN CENTURY COMPANIES INC | 416.0K +66.7K (+19.1%) | 669.7K -283.8K (-29.8%) | 0.16% +0.024 pp | 0.00% 0.000 pp | USD2.75 -41.5% | 3 qtrs — |
| 43 | TWO SIGMA ADVISERS, LP | 399.9K +272.1K (+212.8%) | 643.9K +294.9K (+84.5%) | 0.15% +0.102 pp | 0.00% +0.001 pp | USD2.33 -30.9% | 24 qtrs — |
| 44 | GRAHAM CAPITAL MANAGEMENT, L.P. | 376.6K +146.6K (+63.7%) | 606.3K -21.6K (-3.4%) | 0.14% +0.055 pp | 0.01% +0.005 pp | USD2.31 -30.3% | 4 qtrs — |
| 45 | PRINCIPAL FINANCIAL GROUP INC | 325.9K +99.3K (+43.8%) | 524.7K -94.0K (-15.2%) | 0.12% +0.037 pp | 0.00% +0.000 pp | USD2.33 -30.9% | 7 qtrs — |
| 46 | CANADA PENSION PLAN INVESTMENT BOARD | 322.9K +322.9K (+100.0%) | 519.9K +519.9K (+100.0%) | 0.12% +0.122 pp | 0.00% +0.000 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 47 | UBS ASSET MANAGEMENT AMERICAS INC | 319.8K -7.2K (-2.2%) | 514.9K -377.7K (-42.3%) | 0.12% -0.004 pp | 0.00% 0.000 pp | USD2.81 -42.7% | 3 qtrs — |
| 48 | RHUMBLINE ADVISERS | 317.4K -41.3K (-11.5%) | 511.0K -468.1K (-47.8%) | 0.12% -0.017 pp | 0.00% 0.000 pp | USD1.69 -4.7% | 11 qtrs — |
| 49 | AQUATIC CAPITAL MANAGEMENT LLC | 294.3K -212.6K (-41.9%) | 473.8K -910.1K (-65.8%) | 0.11% -0.082 pp | 0.01% -0.012 pp | USD2.82 -42.9% | 5 qtrs — |
| 50 | WELLS FARGO & COMPANY/MN | 285.8K +95.7K (+50.3%) | 460.1K -58.9K (-11.3%) | 0.11% +0.036 pp | 0.00% +0.000 pp | USD1.81 -11.0% | 47 qtrs — |
| 51 | VOLEON CAPITAL MANAGEMENT LP | 271.3K +59.5K (+28.1%) | 436.8K -141.3K (-24.4%) | 0.10% +0.022 pp | 0.01% -0.005 pp | USD2.48 -35.1% | 2 qtrs — |
| 52 | MACKENZIE FINANCIAL CORP | 272.5K +7.2K (+2.7%) | 432.4K -291.8K (-40.3%) | 0.10% +0.002 pp | 0.00% 0.000 pp | USD1.98 -18.7% | 17 qtrs — |
| 53 | VICTORY CAPITAL MANAGEMENT INC | 250.5K -35.8K (-12.5%) | 403.4K -378.5K (-48.4%) | 0.09% -0.015 pp | 0.00% 0.000 pp | USD2.59 -37.8% | 26 qtrs — |
| 54 | CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 248.2K +504.0 (+0.2%) | 399.6K -276.6K (-40.9%) | 0.09% -0.001 pp | 0.00% 0.000 pp | USD2.62 -38.5% | 7 qtrs — |
| 55 | LEGAL & GENERAL GROUP PLC | 244.0K -1.3K (-0.5%) | 392.8K -276.7K (-41.3%) | 0.09% -0.001 pp | 0.00% 0.000 pp | USD2.62 -38.5% | 7 qtrs — |
| 56 | ALLIANCEBERNSTEIN L.P. | 238.9K +— (+0.0%) | 384.7K -267.6K (-41.0%) | 0.09% -0.001 pp | 0.00% 0.000 pp | USD3.06 -47.4% | 7 qtrs — |
| 57 | BREVAN HOWARD CAPITAL MANAGEMENT LP | 236.6K +158.5K (+202.9%) | 381.0K +167.7K (+78.6%) | 0.09% +0.060 pp | 0.00% +0.003 pp | USD2.05 -21.5% | 3 qtrs — |
| 58 | PANAGORA ASSET MANAGEMENT INC | 236.1K -53.0 (0.0%) | 380.1K -264.6K (-41.0%) | 0.09% -0.001 pp | 0.00% -0.001 pp | USD3.54 -54.5% | 3 qtrs — |
| 59 | ALPS ADVISORS INC | 217.9K +91.8K (+72.8%) | 350.8K +6.7K (+1.9%) | 0.08% +0.034 pp | 0.00% +0.000 pp | USD2.78 -42.1% | 3 qtrs — |
| 60 | PRICE T ROWE ASSOCIATES INC /MD/ | 212.7K +9.5K (+4.7%) | 343.0K -212.0K (-38.2%) | 0.08% +0.003 pp | 0.00% +0.000 pp | USD1.83 -12.0% | 32 qtrs — |
| 61 | MAN GROUP PLC | 208.6K +84.2K (+67.6%) | 335.8K -3.8K (-1.1%) | 0.08% +0.031 pp | 0.00% +0.000 pp | USD2.46 -34.6% | 3 qtrs — |
| 62 | SAPIENT CAPITAL LLC | 200.0K +— (+0.0%) | 318.0K -224.0K (-41.3%) | 0.08% -0.001 pp | 0.00% -0.004 pp | USD1.24 +29.8% | 9 qtrs — |
| 63 | JPMORGAN CHASE & CO | 194.0K -800.2K (-80.5%) | 312.4K -2.4M (-88.5%) | 0.07% -0.305 pp | 0.00% 0.000 pp | USD2.81 -42.7% | 33 qtrs — |
| 64 | RUSSELL INVESTMENTS GROUP, LTD. | 193.7K +61.3K (+46.3%) | 311.9K -49.6K (-13.7%) | 0.07% +0.023 pp | 0.00% 0.000 pp | USD4.07 -60.4% | 25 qtrs — |
| 65 | PROFUND ADVISORS LLC | 184.7K +80.7K (+77.6%) | 297.3K +13.5K (+4.8%) | 0.07% +0.030 pp | 0.01% 0.000 pp | USD2.09 -23.0% | 5 qtrs — |
| 66 | FRANKLIN RESOURCES INC | 181.6K -2.5M (-93.2%) | 292.4K -7.0M (-96.0%) | 0.07% -0.952 pp | 0.00% -0.002 pp | USD1.89 -14.8% | 6 qtrs — |
| 67 | WEALTHSPIRE ADVISORS, LLC | 180.0K +110.0K (+157.1%) | 289.8K +98.7K (+51.7%) | 0.07% +0.041 pp | 0.00% +0.001 pp | USD2.05 -21.5% | 2 qtrs — |
| 68 | SG AMERICAS SECURITIES, LLC | 173.5K +57.1K (+49.1%) | 279.0K -39.0K (-12.3%) | 0.07% +0.021 pp | 0.00% -0.001 pp | USD2.36 -31.8% | 7 qtrs — |
| 69 | ROUND ROCK ADVISORS, LLC | 166.1K +22.8K (+15.9%) | 267.4K -159.5K (-37.4%) | 0.06% +0.008 pp | 0.04% -0.027 pp | USD2.58 -37.6% | 2 qtrs — |
| 70 | DEUTSCHE BANK AG\ | 164.7K +8.1K (+5.2%) | 265.1K -162.3K (-38.0%) | 0.06% +0.003 pp | 0.00% 0.000 pp | USD1.73 -6.9% | 6 qtrs — |
| 71 | CREATIVE PLANNING | 146.7K -135.8K (-48.1%) | 236.2K -535.0K (-69.4%) | 0.06% -0.052 pp | 0.00% 0.000 pp | USD1.93 -16.6% | 10 qtrs — |
| 72 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 146.7K +7.0K (+5.0%) | 235.6K -145.4K (-38.2%) | 0.06% +0.002 pp | 0.00% 0.000 pp | USD1.59 +1.3% | 6 qtrs — |
| 73 | STATE OF ALASKA, DEPARTMENT OF REVENUE | 146.1K +130.5K (+834.9%) | 235.0K +193.0K (+459.5%) | 0.06% +0.049 pp | 0.00% +0.002 pp | USD1.73 -6.9% | 2 qtrs — |
| 74 | GROUP ONE TRADING, L.P. | 133.0K +133.0K (+100.0%) | 214.2K +214.2K (+100.0%) | 0.05% +0.050 pp | 0.00% +0.000 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 75 | ENTRYPOINT CAPITAL, LLC | 127.5K +83.1K (+186.8%) | 205.3K +83.9K (+69.2%) | 0.05% +0.031 pp | 0.08% +0.033 pp | USD2.29 -29.7% | 3 qtrs — |
| 76 | METLIFE INVESTMENT MANAGEMENT, LLC | 125.5K -9.7K (-7.2%) | 202.0K -167.0K (-45.2%) | 0.05% -0.004 pp | 0.00% -0.001 pp | USD1.89 -14.8% | 7 qtrs — |
| 77 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 120.4K -5.8K (-4.6%) | 193.8K -150.7K (-43.7%) | 0.05% -0.003 pp | 0.00% 0.000 pp | USD2.02 -20.3% | 6 qtrs — |
| 78 | INTECH INVESTMENT MANAGEMENT LLC | 103.4K +1.4K (+1.4%) | 166.5K -111.9K (-40.2%) | 0.04% +0.000 pp | 0.00% -0.001 pp | USD1.90 -15.3% | 6 qtrs — |
| 79 | OXFORD ASSET MANAGEMENT LLP | 100.0K +100.0K (+100.0%) | 161.1K +161.1K (+100.0%) | 0.04% +0.038 pp | 0.07% +0.066 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 80 | FIDUCIARY TRUST CO | 100.0K +100.0K (+100.0%) | 161.0K +161.0K (+100.0%) | 0.04% +0.038 pp | 0.00% +0.002 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 81 | LAZARD ASSET MANAGEMENT LLC | 94.6K +69.4K (+275.6%) | 152.2K +83.5K (+121.5%) | 0.04% +0.026 pp | 0.00% +0.000 pp | USD2.15 -25.1% | 3 qtrs — |
| 82 | TWO SIGMA INVESTMENTS, LP | 90.6K +90.6K (+100.0%) | 145.9K +145.9K (+100.0%) | 0.03% +0.034 pp | 0.00% +0.000 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 83 | VIRGINIA RETIREMENT SYSTEMS ET AL | 85.0K +85.0K (+100.0%) | 136.9K +136.9K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.001 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 84 | RAYMOND JAMES FINANCIAL INC | 80.6K +10.8K (+15.5%) | 129.7K -60.8K (-31.9%) | 0.03% +0.004 pp | 0.00% +0.000 pp | USD2.15 -25.1% | 5 qtrs — |
| 85 | NEW YORK STATE COMMON RETIREMENT FUND | 79.1K +— (+0.0%) | 127.4K -88.6K (-41.0%) | 0.03% 0.000 pp | 0.00% 0.000 pp | USD2.66 -39.5% | 7 qtrs — |
| 86 | POLYMER CAPITAL MANAGEMENT (US) LLC | 72.8K +54.6K (+299.4%) | 117.2K +67.5K (+135.5%) | 0.03% +0.021 pp | 0.01% +0.007 pp | USD2.04 -21.1% | 3 qtrs — |
| 87 | POLICE & FIREMEN'S RETIREMENT SYSTEM OF NEW JERSEY | 69.1K +— (+0.0%) | 111.2K -77.4K (-41.0%) | 0.03% 0.000 pp | 0.00% -0.001 pp | USD2.40 -32.9% | 5 qtrs — |
| 88 | ARIZONA STATE RETIREMENT SYSTEM | 68.8K -8.6K (-11.1%) | 110.8K -100.6K (-47.6%) | 0.03% -0.004 pp | 0.00% -0.001 pp | USD2.73 -41.0% | 2 qtrs — |
| 89 | ADVISOR GROUP HOLDINGS, INC. | 65.2K -1.1K (-1.6%) | 105.0K -102.5K (-49.4%) | 0.02% -0.001 pp | 0.00% 0.000 pp | USD2.51 -35.9% | 12 qtrs — |
| 90 | WINTON GROUP LTD | 65.2K +65.2K (+100.0%) | 104.9K +104.9K (+100.0%) | 0.02% +0.025 pp | 0.00% +0.004 pp | USD1.61 +0.0% | 1 qtrs NEW |
| 91 | LPL FINANCIAL LLC | 61.2K +11.4K (+23.0%) | 98.5K -37.3K (-27.5%) | 0.02% +0.004 pp | 0.00% +0.000 pp | USD1.45 +11.0% | 8 qtrs — |
| 92 | CWA ASSET MANAGEMENT GROUP, LLC | 59.0K +— (+0.0%) | 95.0K -66.1K (-41.0%) | 0.02% 0.000 pp | 0.00% -0.003 pp | USD1.68 -4.2% | 6 qtrs — |
| 93 | ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 55.5K +— (+0.0%) | 89.3K -62.1K (-41.0%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD2.73 -41.0% | 2 qtrs — |
| 94 | KLP KAPITALFORVALTNING AS | 54.8K +— (+0.0%) | 88.2K -61.4K (-41.0%) | 0.02% 0.000 pp | 0.00% 0.000 pp | USD2.73 -41.0% | 2 qtrs — |
| 95 | ORCHARD CAPITAL MANAGEMENT, LLC | 53.5K +— (+0.0%) | 86.2K -59.9K (-41.0%) | 0.02% 0.000 pp | 0.07% -0.052 pp | USD2.32 -30.6% | 21 qtrs — |
Ownership breakdown by holder
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
1
Sells
0
Shares acquired
214.4K
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+214,400
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-01 | Vickers Philip J. | Director | A-Award | A | Stock Option (Right to buy) | 214,400 | 1.41 | 302.3K | 214,400 | D | ↗ |
| 2026-03-04 | Butler John P. | Director / Officer | P-Purchase | A | Common Stock | 69,270 | 1.25 | 86.6K | 3,367,064 | D | ↗ |
| 2026-02-02 | Rucci Carolyn M. | Officer | S-Sale | D | Common Stock | 16,846 | 1.39 | 23.4K | 641,304 | D | ↗ |
| 2026-02-02 | Ostrowski Erik | Officer | S-Sale | D | Common Stock | 34,951 | 1.39 | 48.6K | 672,635 | D | ↗ |
| 2026-02-02 | Malabre Richard C | Officer | S-Sale | D | Common Stock | 13,382 | 1.39 | 18.6K | 299,390 | D | ↗ |
| 2026-02-02 | Grund Nicholas | Officer | S-Sale | D | Common Stock | 31,244 | 1.39 | 43.4K | 561,750 | D | ↗ |
| 2026-02-02 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 114,891 | 1.39 | 159.7K | 3,206,233 | D | ↗ |
| 2026-02-02 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 20,701 | 1.39 | 28.8K | 948,432 | D | ↗ |
| 2026-01-30 | Rucci Carolyn M. | Officer | A-Award | A | Stock Option (Right to buy) | 270,000 | 1.41 | 380.7K | 270,000 | D | ↗ |
| 2026-01-30 | Ostrowski Erik | Officer | A-Award | A | Stock Option (Right to buy) | 320,000 | 1.41 | 451.2K | 320,000 | D | ↗ |
| 2026-01-30 | Malabre Richard C | Officer | A-Award | A | Common Stock | 79,000 | 0.00 | — | 348,914 | D | ↗ |
| 2026-01-30 | Grund Nicholas | Officer | A-Award | A | Stock Option (Right to buy) | 320,000 | 1.41 | 451.2K | 320,000 | D | ↗ |
| 2026-01-30 | Butler John P. | Director / Officer | A-Award | A | Stock Option (Right to buy) | 1,115,000 | 1.41 | 1.57M | 1,115,000 | D | ↗ |
| 2026-01-30 | Burke Steven Keith | Officer | A-Award | A | Stock Option (Right to buy) | 320,000 | 1.41 | 451.2K | 320,000 | D | ↗ |
| 2026-01-26 | Rucci Carolyn M. | Officer | — | — | Employee Stock Option (right to buy) | 27,900 | 2.16 | 60.3K | 0 | D | ↗ |
| 2025-06-30 | Ostrowski Erik | Officer | S-Sale | D | Common Stock | 41,314 | 3.67 | 151.6K | 503,586 | D | ↗ |
| 2025-06-10 | ZUMWALT LEANNE M | Director | A-Award | A | Stock Option (Right to buy) | 53,600 | 3.92 | 210.1K | 53,600 | D | ↗ |
| 2025-06-10 | Wolf Myles | Director | A-Award | A | Common Stock | 35,700 | 0.00 | — | 133,381 | D | ↗ |
| 2025-06-10 | Smith Cynthia | Director | A-Award | A | Common Stock | 35,700 | 0.00 | — | 160,933 | D | ↗ |
| 2025-06-10 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 53,600 | 3.92 | 210.1K | 53,600 | D | ↗ |
| 2025-06-10 | GILMAN STEVEN C | Director | A-Award | A | Stock Option (Right to buy) | 53,600 | 3.92 | 210.1K | 53,600 | D | ↗ |
| 2025-06-10 | FRIESON RON | Director | A-Award | A | Common Stock | 35,700 | 0.00 | — | 129,500 | D | ↗ |
| 2025-06-10 | ADAMS ADRIAN | Director | A-Award | A | Stock Option (Right to buy) | 53,600 | 3.92 | 210.1K | 53,600 | D | ↗ |
| 2025-06-09 | Malabre Richard C | Officer | S-Sale | D | Common Stock | 15,000 | 4.01 | 60.2K | 266,914 | D | ↗ |
| 2025-06-04 | Malabre Richard C | Officer | S-Sale | D | Common Stock | 13,334 | 3.53 | 47.1K | 266,914 | D | ↗ |
| 2025-03-03 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 46,409 | 1.83 | 84.9K | 2,557,921 | D | ↗ |
| 2025-03-03 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 7,144 | 1.83 | 13.1K | 809,090 | D | ↗ |
| 2025-02-03 | Malabre Richard C | Officer | S-Sale | D | Common Stock | 30,202 | 2.10 | 63.4K | 280,248 | D | ↗ |
| 2025-02-03 | Grund Nicholas | Officer | S-Sale | D | Common Stock | 55,621 | 2.10 | 116.8K | 442,579 | D | ↗ |
| 2025-02-03 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 97,982 | 2.10 | 205.8K | 2,604,330 | D | ↗ |
| 2025-02-03 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 27,236 | 2.10 | 57.2K | 816,234 | D | ↗ |
| 2025-01-31 | Ostrowski Erik | Officer | A-Award | A | Common Stock | 194,900 | 0.00 | — | 544,900 | D | ↗ |
| 2025-01-31 | Malabre Richard C | Officer | A-Award | A | Common Stock | 85,000 | 0.00 | — | 310,450 | D | ↗ |
| 2025-01-31 | Grund Nicholas | Officer | A-Award | A | Common Stock | 194,900 | 0.00 | — | 498,200 | D | ↗ |
| 2025-01-31 | Butler John P. | Director / Officer | A-Award | A | Stock Option (Right to buy) | 1,051,400 | 2.24 | 2.36M | 1,051,400 | D | ↗ |
| 2025-01-31 | Burke Steven Keith | Officer | A-Award | A | Common Stock | 194,900 | 0.00 | — | 866,740 | D | ↗ |
| 2025-01-17 | FRIESON RON | Director | M-Exempt | A | Common Stock | 20,100 | 0.45 | 9.0K | 93,800 | D | ↗ |
| 2024-06-28 | Ostrowski Erik | Officer | A-Award | A | Common Stock | 350,000 | 0.00 | — | 350,000 | — | ↗ |
| 2024-06-24 | Ostrowski Erik | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-06-06 | ZUMWALT LEANNE M | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-06-06 | Wolf Myles | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-06-06 | Smith Cynthia | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-06-06 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-06-06 | GILMAN STEVEN C | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 117,130 | — | ↗ |
| 2024-06-06 | FRIESON RON | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-06-06 | ADAMS ADRIAN | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.07 | 48.2K | 45,000 | — | ↗ |
| 2024-05-13 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 12,016 | 1.26 | 15.1K | 651,243 | — | ↗ |
| 2024-05-13 | Dahan Michel | Officer | S-Sale | D | Common Stock | 34,840 | 1.26 | 43.9K | 672,092 | — | ↗ |
| 2024-02-29 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 5,974 | 1.58 | 9.4K | 663,259 | — | ↗ |
| 2024-02-29 | Dahan Michel | Officer | S-Sale | D | Common Stock | 8,661 | 1.58 | 13.7K | 706,932 | — | ↗ |
| 2024-02-29 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 46,570 | 1.58 | 73.6K | 2,044,580 | — | ↗ |
| 2024-02-29 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 7,169 | 1.58 | 11.3K | 695,840 | — | ↗ |
| 2024-02-27 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 7,411 | 1.52 | 11.3K | 669,233 | — | ↗ |
| 2024-02-27 | Dahan Michel | Officer | S-Sale | D | Common Stock | 10,744 | 1.52 | 16.3K | 715,593 | — | ↗ |
| 2024-02-27 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 37,733 | 1.52 | 57.4K | 2,091,150 | — | ↗ |
| 2024-02-27 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 8,367 | 1.52 | 12.7K | 703,009 | — | ↗ |
| 2024-02-01 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 46,489 | 1.68 | 78.1K | 2,128,883 | — | ↗ |
| 2024-02-01 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 24,311 | 1.68 | 40.8K | 711,376 | — | ↗ |
| 2024-01-31 | Snow Ellen | Officer | A-Award | A | Stock Option (Right to buy) | 224,000 | 1.68 | 376.3K | 224,000 | — | ↗ |
| 2024-01-31 | Malabre Richard C | Officer | A-Award | A | Common Stock | 223,950 | 0.00 | — | 223,950 | — | ↗ |
| 2024-01-31 | Hadas Nicole R. | Officer | A-Award | A | Common Stock | 149,300 | 0.00 | — | 676,644 | — | ↗ |
| 2024-01-31 | Grund Nicholas | Officer | A-Award | A | Common Stock | 303,300 | 0.00 | — | 303,300 | — | ↗ |
| 2024-01-31 | Dahan Michel | Officer | A-Award | A | Stock Option (Right to buy) | 224,000 | 1.68 | 376.3K | 224,000 | — | ↗ |
| 2024-01-31 | Butler John P. | Director / Officer | A-Award | A | Stock Option (Right to buy) | 905,200 | 1.68 | 1.52M | 905,200 | — | ↗ |
| 2024-01-31 | Burke Steven Keith | Officer | A-Award | A | Stock Option (Right to buy) | 303,300 | 1.68 | 509.5K | 303,300 | — | ↗ |
| 2024-01-08 | Malabre Richard C | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2024-01-08 | Grund Nicholas | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-25 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 27,000 | 1.15 | 31.1K | 668,840 | — | ↗ |
| 2023-07-31 | Snow Ellen | Officer | A-Award | A | Stock Option (Right to buy) | 560,000 | 1.67 | 935.2K | 560,000 | — | ↗ |
| 2023-07-10 | Snow Ellen | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-06-06 | ZUMWALT LEANNE M | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 43,700 | — | ↗ |
| 2023-06-06 | Wolf Myles | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.20 | 54.0K | 45,000 | — | ↗ |
| 2023-06-06 | Smith Cynthia | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.20 | 54.0K | 45,000 | — | ↗ |
| 2023-06-06 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.20 | 54.0K | 45,000 | — | ↗ |
| 2023-06-06 | GILMAN STEVEN C | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.20 | 54.0K | 45,000 | — | ↗ |
| 2023-06-06 | FRIESON RON | Director | A-Award | A | Common Stock | 30,000 | 0.00 | — | 43,700 | — | ↗ |
| 2023-06-06 | ADAMS ADRIAN | Director | A-Award | A | Stock Option (Right to buy) | 45,000 | 1.20 | 54.0K | 45,000 | — | ↗ |
| 2023-05-25 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 63,186 | 1.22 | 77.3K | 524,344 | — | ↗ |
| 2023-05-25 | Dahan Michel | Officer | S-Sale | D | Common Stock | 95,478 | 1.22 | 116.8K | 574,037 | — | ↗ |
| 2023-05-24 | Hadas Nicole R. | Officer | A-Award | A | Employee Stock Option (Right to buy) | 200,000 | 0.41 | 82.0K | 200,000 | — | ↗ |
| 2023-05-24 | Dahan Michel | Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 669,515 | — | ↗ |
| 2023-05-16 | Spellman David A | Officer | S-Sale | D | Common Stock | 63,567 | 1.07 | 67.9K | 446,483 | — | ↗ |
| 2023-05-16 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 63,567 | 1.07 | 67.9K | 530,487 | — | ↗ |
| 2023-05-12 | Hadas Nicole R. | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 387,530 | — | ↗ |
| 2023-05-12 | Dahan Michel | Officer | A-Award | A | Common Stock | 200,000 | 0.00 | — | 469,515 | — | ↗ |
| 2023-03-01 | Spellman David A | Officer | S-Sale | D | Common Stock | 6,400 | 0.88 | 5.6K | 510,860 | — | ↗ |
| 2023-03-01 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 1,088 | 0.88 | 954.72 | 287,530 | — | ↗ |
| 2023-03-01 | Dahan Michel | Officer | S-Sale | D | Common Stock | 1,878 | 0.88 | 1.6K | 269,515 | — | ↗ |
| 2023-03-01 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 6,370 | 0.88 | 5.6K | 1,568,872 | — | ↗ |
| 2023-03-01 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 1,110 | 0.88 | 974.03 | 594,054 | — | ↗ |
| 2023-02-27 | Spellman David A | Officer | S-Sale | D | Common Stock | 7,539 | 0.81 | 6.1K | 517,260 | — | ↗ |
| 2023-02-27 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 6,677 | 0.81 | 5.4K | 300,564 | — | ↗ |
| 2023-02-27 | Dahan Michel | Officer | S-Sale | D | Common Stock | 10,090 | 0.81 | 8.2K | 289,927 | — | ↗ |
| 2023-02-27 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 38,632 | 0.81 | 31.4K | 1,660,740 | — | ↗ |
| 2023-02-27 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 7,539 | 0.81 | 6.1K | 608,177 | — | ↗ |
| 2023-01-31 | Spellman David A | Officer | A-Award | A | Common Stock | 196,200 | 0.00 | — | 524,799 | — | ↗ |
| 2023-01-31 | Butler John P. | Director / Officer | A-Award | A | Stock Option (Right to buy) | 875,000 | 0.63 | 551.3K | 875,000 | — | ↗ |
| 2023-01-31 | Burke Steven Keith | Officer | A-Award | A | Stock Option (Right to buy) | 294,300 | 0.63 | 185.4K | 294,300 | — | ↗ |
| 2022-08-31 | Burke Steven Keith | Director / Officer | S-Sale | D | Common Stock | 1,147 | 0.36 | 415.79 | 418,016 | — | ↗ |
| 2022-06-08 | ZUMWALT LEANNE M | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2022-06-08 | Wolf Myles | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2022-06-08 | Spellman David A | Officer | A-Award | A | Stock Option (Right to buy) | 200,000 | 0.45 | 90.0K | 200,000 | — | ↗ |
| 2022-06-08 | Smith Cynthia | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 65,233 | — | ↗ |
| 2022-06-08 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2022-06-08 | GILMAN STEVEN C | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2022-06-08 | FRIESON RON | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 13,700 | — | ↗ |
| 2022-06-08 | ADAMS ADRIAN | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2022-06-03 | GILMAN STEVEN C | Director | S-Sale | D | Common Stock | 4,567 | 0.36 | 1.7K | 43,430 | — | ↗ |
| 2022-05-12 | Cotreau Violetta | Director / Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 219,954 | — | ↗ |
| 2022-05-12 | Burke Steven Keith | Director / Officer | A-Award | A | Stock Option (Right to buy) | 200,000 | 0.00 | — | 200,000 | — | ↗ |
| 2022-03-01 | Spellman David A | Officer | S-Sale | D | Common Stock | 803 | 2.17 | 1.7K | 128,599 | — | ↗ |
| 2022-03-01 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 6,873 | 2.17 | 14.9K | 308,875 | — | ↗ |
| 2022-03-01 | Faulkingham Dell | Officer | S-Sale | D | Common Stock | 957 | 2.17 | 2.1K | 173,841 | — | ↗ |
| 2022-03-01 | Dahan Michel | Officer | S-Sale | D | Common Stock | 6,873 | 2.17 | 14.9K | 295,249 | — | ↗ |
| 2022-03-01 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 4,131 | 2.17 | 9.0K | 1,403,247 | — | ↗ |
| 2022-03-01 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 1,100 | 2.17 | 2.4K | 217,663 | — | ↗ |
| 2022-02-28 | Spellman David A | Officer | A-Award | A | Employee Stock Option (Right to buy) | 225,000 | 2.16 | 486.0K | 225,000 | — | ↗ |
| 2022-02-28 | Hadas Nicole R. | Officer | A-Award | A | Employee Stock Option (Right to buy) | 200,000 | 2.16 | 432.0K | 200,000 | — | ↗ |
| 2022-02-28 | Faulkingham Dell | Officer | S-Sale | D | Common Stock | 6,479 | 2.15 | 14.0K | 130,546 | — | ↗ |
| 2022-02-28 | Dahan Michel | Officer | A-Award | A | Employee Stock Option (Right to buy) | 200,000 | 2.16 | 432.0K | 200,000 | — | ↗ |
| 2022-02-28 | Cotreau Violetta | Officer | A-Award | A | Employee Stock Option (Right to buy) | 70,000 | 2.16 | 151.2K | 70,000 | — | ↗ |
| 2022-02-28 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 25,053 | 2.15 | 54.0K | 1,164,095 | — | ↗ |
| 2022-02-28 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 7,400 | 2.15 | 15.9K | 163,819 | — | ↗ |
| 2022-01-03 | Cotreau Violetta | Officer | S-Sale | D | Common Stock | 5,833 | 2.29 | 13.3K | 33,067 | — | ↗ |
| 2021-11-01 | FRIESON RON | Director | A-Award | A | Stock Option (Right to buy) | 80,200 | 3.13 | 251.0K | 80,200 | — | ↗ |
| 2021-09-30 | Spellman David A | Officer | A-Award | A | Employee Stock Option (Right to Buy) | 200,000 | 2.88 | 576.0K | 200,000 | — | ↗ |
| 2021-08-31 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 1,042 | 2.83 | 2.9K | 171,219 | — | ↗ |
| 2021-06-07 | GILMAN STEVEN C | Director | S-Sale | D | Common Stock | 4,567 | 3.32 | 15.2K | 47,997 | — | ↗ |
| 2021-06-02 | Wolf Myles | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 3.37 | 67.7K | 20,100 | — | ↗ |
| 2021-06-02 | Smith Cynthia | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 51,533 | — | ↗ |
| 2021-06-02 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 3.37 | 67.7K | 20,100 | — | ↗ |
| 2021-06-02 | Heffernan Michael Thomas | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 48,586 | — | ↗ |
| 2021-06-02 | GILMAN STEVEN C | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 3.37 | 67.7K | 20,100 | — | ↗ |
| 2021-06-02 | ADAMS ADRIAN | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 3.37 | 67.7K | 20,100 | — | ↗ |
| 2021-04-01 | Spellman David A | Officer | S-Sale | D | Common Stock | 790 | 3.40 | 2.7K | 76,802 | — | ↗ |
| 2021-04-01 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 1,060 | 3.40 | 3.6K | 272,303 | — | ↗ |
| 2021-04-01 | Faulkingham Dell | Officer | S-Sale | D | Common Stock | 952 | 3.40 | 3.2K | 137,025 | — | ↗ |
| 2021-04-01 | Dahan Michel | Officer | S-Sale | D | Common Stock | 1,211 | 3.40 | 4.1K | 265,550 | — | ↗ |
| 2021-04-01 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 4,109 | 3.40 | 14.0K | 1,152,153 | — | ↗ |
| 2021-04-01 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 1,081 | 3.40 | 3.7K | 170,761 | — | ↗ |
| 2021-03-16 | Spellman David A | Officer | A-Award | A | Common Stock | 7,592 | 0.00 | — | 77,592 | — | ↗ |
| 2021-03-16 | Hadas Nicole R. | Officer | A-Award | A | Common Stock | 10,192 | 0.00 | — | 273,363 | — | ↗ |
| 2021-03-16 | Faulkingham Dell | Officer | A-Award | A | Common Stock | 9,152 | 0.00 | — | 137,977 | — | ↗ |
| 2021-03-16 | Dahan Michel | Officer | A-Award | A | Common Stock | 11,648 | 0.00 | — | 266,761 | — | ↗ |
| 2021-03-16 | Butler John P. | Director / Officer | A-Award | A | Common Stock | 39,520 | 0.00 | — | 1,156,262 | — | ↗ |
| 2021-03-16 | Burke Steven Keith | Director / Officer | A-Award | A | Common Stock | 10,400 | 0.00 | — | 171,842 | — | ↗ |
| 2021-03-01 | Hadas Nicole R. | Officer | S-Sale | D | Common Stock | 7,976 | 3.40 | 27.1K | 263,171 | — | ↗ |
| 2021-03-01 | Faulkingham Dell | Officer | S-Sale | D | Common Stock | 6,749 | 3.40 | 22.9K | 128,825 | — | ↗ |
| 2021-03-01 | Dahan Michel | Officer | S-Sale | D | Common Stock | 7,945 | 3.40 | 27.0K | 255,113 | — | ↗ |
| 2021-03-01 | Butler John P. | Director / Officer | S-Sale | D | Common Stock | 25,316 | 3.40 | 86.0K | 1,141,416 | — | ↗ |
| 2021-03-01 | Burke Steven Keith | Officer | S-Sale | D | Common Stock | 7,558 | 3.40 | 25.7K | 161,442 | — | ↗ |
| 2021-02-26 | Spellman David A | Officer | A-Award | A | Employee Stock Option (Right to buy) | 120,000 | 3.46 | 415.2K | 120,000 | — | ↗ |
| 2021-02-26 | Hadas Nicole R. | Officer | A-Award | A | Common Stock | 62,000 | 0.00 | — | 277,456 | — | ↗ |
| 2021-02-26 | Faulkingham Dell | Officer | A-Award | A | Employee Stock Option (Right to buy) | 110,000 | 3.46 | 380.6K | 110,000 | — | ↗ |
| 2021-02-26 | Dahan Michel | Officer | A-Award | A | Common Stock | 62,000 | 0.00 | — | 269,660 | — | ↗ |
| 2021-02-26 | Cotreau Violetta | Officer | A-Award | A | Employee Stock Option (Right to buy) | 44,200 | 3.46 | 152.9K | 44,200 | — | ↗ |
| 2021-02-26 | Butler John P. | Director / Officer | A-Award | A | Employee Stock Option (Right to buy) | 403,600 | 3.46 | 1.40M | 403,600 | — | ↗ |
| 2021-02-26 | Burke Steven Keith | Officer | A-Award | A | Common Stock | 70,000 | 0.00 | — | 169,000 | — | ↗ |
| 2021-02-16 | ZUMWALT LEANNE M | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-01-26 | Cotreau Violetta | Director / Officer | — | D | Employee Stock Option (Right to buy) | 42,000 | 2.80 | 117.6K | 0 | — | ↗ |
| 2020-06-30 | Spellman David A | Officer | A-Award | A | Employee Stock Option (Right to buy) | 280,000 | 13.58 | 3.80M | 280,000 | — | ↗ |
| 2020-06-29 | Spellman David A | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-06-08 | Smith Cynthia | Director | S-Sale | D | Common Stock | 4,567 | 12.10 | 55.3K | 37,833 | — | ↗ |
| 2020-06-08 | GOWEN MAXINE | Director | S-Sale | D | Common Stock | 4,567 | 12.05 | 55.0K | 24,133 | — | ↗ |
| 2020-06-05 | Smith Cynthia | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 42,400 | — | ↗ |
| 2020-06-05 | ROGERS MICHAEL W | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 38,629 | — | ↗ |
| 2020-06-05 | Heffernan Michael Thomas | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 11.96 | 240.4K | 20,100 | — | ↗ |
| 2020-06-05 | GOWEN MAXINE | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 11.96 | 240.4K | 20,100 | — | ↗ |
| 2020-06-05 | GILMAN STEVEN C | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2020-06-05 | Enyedy Mark J | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 11.96 | 240.4K | 20,100 | — | ↗ |
| 2020-06-05 | ADAMS ADRIAN | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 77,400 | — | ↗ |
| 2020-06-01 | Faulkingham Dell | Officer | S-Sale | D | Common Stock | 6,426 | 11.58 | 74.4K | 73,574 | — | ↗ |
| 2020-04-06 | Wolf Myles | Director | A-Award | A | Stock Option (Right to buy) | 80,200 | 7.09 | 568.6K | 80,200 | — | ↗ |
| 2020-02-28 | Tubridy Karen L | Officer | S-Sale | D | Common Stock | 3,454 | 8.70 | 30.0K | 84,679 | — | ↗ |
| 2020-02-28 | Hadas Nicole R. | Officer | A-Award | A | Stock Option (Right to buy) | 105,000 | 8.87 | 931.4K | 105,000 | — | ↗ |
| 2020-02-28 | Faulkingham Dell | Officer | A-Award | A | Stock Option (Right to buy) | 94,000 | 8.87 | 833.8K | 94,000 | — | ↗ |
| 2020-02-28 | Dahan Michel | Officer | A-Award | A | Stock Option (Right to buy) | 120,000 | 8.87 | 1.06M | 120,000 | — | ↗ |
| 2020-02-28 | Butler John P. | Director / Officer | A-Award | A | Stock Option (Right to buy) | 403,600 | 8.87 | 3.58M | 403,600 | — | ↗ |
| 2020-02-28 | Burke Steven Keith | Officer | A-Award | A | Common Stock | 62,000 | 0.00 | — | 99,000 | — | ↗ |
| 2020-02-28 | Amello Jason | Officer | S-Sale | D | Common Stock | 6,976 | 8.70 | 60.7K | 144,642 | — | ↗ |
| 2019-12-31 | Butler John P. | Director / Officer | — | D | Common Stock | 0 | 0.00 | — | 789,232 | — | ↗ |
| 2019-11-20 | Smith Cynthia | Director | P-Purchase | A | Common Stock | 15,000 | 3.52 | 52.8K | 28,700 | — | ↗ |
| 2019-11-20 | GILMAN STEVEN C | Director | P-Purchase | A | Common Stock | 5,800 | 3.43 | 19.9K | 29,731 | — | ↗ |
| 2019-11-20 | Butler John P. | Director / Officer | P-Purchase | A | Common Stock | 50,000 | 3.44 | 172.0K | 887,732 | — | ↗ |
| 2019-11-20 | Burke Steven Keith | Officer | P-Purchase | A | Common Stock | 27,000 | 3.58 | 96.7K | 37,000 | — | ↗ |
| 2019-11-20 | ADAMS ADRIAN | Director | P-Purchase | A | Common Stock | 50,000 | 3.41 | 170.5K | 63,700 | — | ↗ |
| 2019-08-30 | Burke Steven Keith | Officer | A-Award | A | Common Stock | 10,000 | 0.00 | — | 10,000 | — | ↗ |
| 2019-08-01 | Burke Steven Keith | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2019-06-06 | Smith Cynthia | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 13,700 | — | ↗ |
| 2019-06-06 | ROGERS MICHAEL W | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 4.23 | 85.0K | 20,100 | — | ↗ |
| 2019-06-06 | Morrison Jodie Pope | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 4.23 | 85.0K | 20,100 | — | ↗ |
| 2019-06-06 | Heffernan Michael Thomas | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 4.23 | 85.0K | 20,100 | — | ↗ |
| 2019-06-06 | GOWEN MAXINE | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 0.00 | — | 20,100 | — | ↗ |
| 2019-06-06 | GILMAN STEVEN C | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 23,931 | — | ↗ |
| 2019-06-06 | Enyedy Mark J | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 17,443 | — | ↗ |
| 2019-06-06 | Canute Scott A | Director | A-Award | A | Stock Option (Right to buy) | 20,100 | 4.23 | 85.0K | 20,100 | — | ↗ |
| 2019-06-06 | ADAMS ADRIAN | Director | A-Award | A | Common Stock | 13,700 | 0.00 | — | 13,700 | — | ↗ |
| 2019-06-03 | Butler John P. | Director / Officer | M-Exempt | A | Common Stock | 287,000 | 0.47 | 134.9K | 836,232 | — | ↗ |
| 2019-05-31 | Faulkingham Dell | Officer | A-Award | A | Employee Stock Option (Right to buy) | 250,000 | 4.45 | 1.11M | 250,000 | — | ↗ |
| 2019-05-06 | Faulkingham Dell | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
Executive team
Top executives
EBIT / Employee
113.0K
Shares Outstanding
268.25M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | John P. Butler, President and Chief Executive Officer | 864.0K | — | 2.16M | 2.02M | 581.0K | 18.2K | 5.65M | 74.11% | ↗ |
| 2 | 2025 | Steven K. Burke, M.D., Senior Vice President, Chief Research & Development and Medical Officer | 600.5K | — | 436.6K | 562.9K | 242.3K | 17.5K | 1.86M | 53.74% | ↗ |
| 3 | 2025 | Erik J. Ostrowski, Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | 552.9K | — | 436.6K | 562.9K | 223.1K | 16.9K | 1.79M | 55.76% | ↗ |
| 4 | 2025 | Nicholas P. Grund, Senior Vice President, Chief Commercial Officer | 506.7K | — | 436.6K | 562.9K | 204.7K | 17.5K | 1.73M | 57.83% | ↗ |
| 5 | 2024 | John P. Butler, President and Chief Executive Officer | 834.0K | — | 1.01M | 1.31M | 1.03M | 64.2K | 4.26M | 54.66% | ↗ |
| 6 | 2024 | Nicholas P. Grund, Senior Vice President, Chief Commercial Officer | 459.4K | — | 509.5K | 660.9K | 206.4K | 18.4K | 1.85M | 63.11% | ↗ |
| 7 | 2024 | Steven K. Burke, M.D., Senior Vice President, Chief Research & Development and Medical Officer | 579.7K | — | 339.7K | 440.6K | 433.9K | 17.3K | 1.81M | 43.08% | ↗ |
| 8 | 2024 | Steven K. Burke, M.D., Senior Vice President, Research Development and Chief Medical Officer | 579.7K | — | 339.7K | 440.6K | 433.9K | 17.3K | 1.81M | 43.08% | ↗ |
| 9 | 2024 | Erik J. Ostrowski, Senior Vice President, Chief Financial Officer, Chief Business Officer and Treasurer | 284.4K | — | 357.0K | 445.3K | 127.8K | 573.00 | 1.22M | 66.03% | ↗ |
| 10 | 2024 | Michel Dahan, Former Senior Vice President, Chief Operating Officer | 251.9K | — | 250.8K | 325.4K | 75.0K | 309.4K | 1.21M | 47.52% | ↗ |
| 11 | 2024 | Ellen E. Snow, Former Senior Vice President, Chief Financial Officer and Treasurer | 99.6K | — | 250.8K | 325.4K | — | 372.8K | 1.05M | 54.95% | ↗ |
| 12 | 2023 | John P. Butler, President and Chief Executive Officer | 795.7K | — | 184.7K | 780.3K | 997.2K | 17.2K | 2.78M | 34.77% | ↗ |
| 13 | 2023 | Ellen E. Snow, Former Senior Vice President, Chief Financial Officer and Treasurer | 216.3K | — | 617.9K | 786.6K | 85.4K | 9.5K | 1.72M | 81.86% | ↗ |
| 14 | 2023 | Michel Dahan, Senior Vice President, Chief Operating Officer | 505.5K | — | 226.0K | — | 499.0K | 14.9K | 1.25M | 18.15% | ↗ |
| 15 | 2023 | Michel Dahan, Former Senior Vice President, Chief Operating Officer | 505.5K | — | 226.0K | — | 499.0K | 14.9K | 1.25M | 18.15% | ↗ |
| 16 | 2023 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | 553.1K | — | 123.6K | 152.1K | 367.8K | 16.5K | 1.21M | 22.72% | ↗ |
| 17 | 2023 | Steven K. Burke, M.D., Senior Vice President, Chief Research & Development and Medical Officer | 553.1K | — | 123.6K | 152.1K | 367.8K | 16.5K | 1.21M | 22.72% | ↗ |
| 18 | 2023 | Steven K. Burke, M.D., Senior Vice President, Research Development and Chief Medical Officer | 553.1K | — | 123.6K | 152.1K | 367.8K | 16.5K | 1.21M | 22.72% | ↗ |
| 19 | 2023 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer | 477.9K | — | 113.0K | — | 438.2K | 17.2K | 1.05M | 10.80% | ↗ |
| 20 | 2023 | David A. Spellman, Former Senior Vice President, Chief Financial Officer and Treasurer | 254.8K | — | 123.6K | 152.1K | 125.0K | 287.2K | 942.6K | 29.24% | ↗ |
| 21 | 2022 | John P. Butler, President and Chief Executive Officer | 765.1K | — | 633.2K | 1.12M | 542.3K | 15.8K | 3.07M | 56.93% | ↗ |
| 22 | 2022 | David A. Spellman, Former Senior Vice President, Chief Financial Officer and Treasurer | 504.7K | 100.0K | 218.6K | 405.3K | 339.6K | 17.7K | 1.59M | 39.34% | ↗ |
| 23 | 2022 | David A. Spellman, Senior Vice President, Chief Financial Officer and Treasurer | 504.7K | 225.0K | 218.6K | 405.3K | 214.6K | 17.7K | 1.59M | 39.34% | ↗ |
| 24 | 2022 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | 526.8K | — | 212.2K | 399.8K | 224.0K | 15.8K | 1.38M | 44.39% | ↗ |
| 25 | 2022 | Steven K. Burke, M.D., Senior Vice President, Research Development and Chief Medical Officer | 526.8K | — | 212.2K | 399.8K | 224.0K | 15.8K | 1.38M | 44.39% | ↗ |
| 26 | 2022 | Michel Dahan, Senior Vice President, Chief Operating Officer | 505.5K | — | 190.6K | 362.1K | 215.0K | 14.3K | 1.29M | 42.93% | ↗ |
| 27 | 2022 | Michel Dahan, Former Senior Vice President, Chief Operating Officer | 505.5K | — | 190.6K | 362.1K | 215.0K | 14.3K | 1.29M | 42.93% | ↗ |
| 28 | 2022 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer | 468.4K | — | 190.6K | 362.1K | 203.2K | 15.8K | 1.24M | 44.57% | ↗ |
| 29 | 2021 | John P. Butler, President and Chief Executive Officer | 718.4K | 75.0K | 821.4K | 951.3K | 552.3K | 15.0K | 3.13M | 56.58% | ↗ |
| 30 | 2021 | David A. Spellman, Senior Vice President, Chief Financial Officer and Treasurer | 473.9K | 75.0K | 242.2K | 688.7K | 234.2K | 7.5K | 1.72M | 54.08% | ↗ |
| 31 | 2021 | David A. Spellman, Former Senior Vice President, Chief Financial Officer and Treasurer | 473.9K | 75.0K | 242.2K | 688.7K | 234.2K | 7.5K | 1.72M | 54.08% | ↗ |
| 32 | 2021 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | 494.6K | 75.0K | 242.2K | 282.8K | 244.4K | 7.5K | 1.35M | 38.99% | ↗ |
| 33 | 2021 | Michel Dahan, Senior Vice President, Chief Operating Officer | 474.6K | 75.0K | 214.5K | 259.3K | 234.6K | 10.0K | 1.27M | 37.37% | ↗ |
| 34 | 2021 | Dell Faulkingham, Senior Vice President, Chief Commercial Officer | 477.1K | 75.0K | 214.5K | 259.3K | 234.6K | 11.2K | 1.27M | 37.37% | ↗ |
| 35 | 2021 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer | 448.7K | 75.0K | 214.5K | 259.3K | 221.8K | 11.2K | 1.23M | 38.51% | ↗ |
| 36 | 2020 | John P. Butler, President and Chief Executive Officer | 696.3K | — | 2.46M | 2.28M | 488.2K | 12.4K | 5.93M | 79.82% | ↗ |
| 37 | 2020 | David A. Spellman, Senior Vice President, Chief Financial Officer and Treasurer | 237.1K | — | 19.1K | 2.36M | 184.0K | 707.00 | 2.80M | 84.96% | ↗ |
| 38 | 2020 | Michel Dahan, Senior Vice President, Chief Operating Officer | 461.1K | — | 679.9K | 677.1K | 184.3K | 9.8K | 2.01M | 67.44% | ↗ |
| 39 | 2020 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | 482.4K | — | 642.2K | 595.3K | 192.1K | 7.5K | 1.92M | 64.47% | ↗ |
| 40 | 2020 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer | 428.0K | — | 640.3K | 592.5K | 174.2K | 9.8K | 1.84M | 66.82% | ↗ |
| 41 | 2020 | Dell Faulkingham, Senior Vice President, Chief Commercial Officer | 464.8K | — | 569.0K | 530.4K | 185.3K | 10.0K | 1.76M | 62.49% | ↗ |
| 42 | 2020 | Jason A. Amello, Former Senior Vice President, Chief Financial Officer and Treasurer | 267.6K | — | 336.4K | 253.9K | — | 168.0K | 1.03M | 57.53% | ↗ |
| 43 | 2019 | John P. Butler, President and Chief Executive Officer | 647.5K | — | 1.74M | 1.56M | 368.2K | 2.0K | 4.32M | 76.42% | ↗ |
| 44 | 2019 | Jason A. Amello, Senior Vice President, Chief Financial Officer and Treasurer | 418.0K | — | 473.2K | 444.5K | 158.1K | 2.0K | 1.50M | 61.35% | ↗ |
| 45 | 2019 | Jason A. Amello, Former Senior Vice President, Chief Financial Officer and Treasurer | 418.0K | — | 473.2K | 444.5K | 158.1K | 2.0K | 1.50M | 61.35% | ↗ |
| 46 | 2019 | Michel Dahan, Senior Vice President, Chief Operating Officer | 409.9K | — | 473.2K | 444.5K | 155.7K | 2.0K | 1.49M | 61.79% | ↗ |
| 47 | 2019 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer and Corporate Secretary | 358.9K | — | 473.2K | 444.5K | 136.5K | 2.0K | 1.42M | 64.85% | ↗ |
| 48 | 2019 | Rita Jain, M.D., former Senior Vice President, Chief Medical Officer | 210.8K | — | 582.4K | 511.1K | — | 2.0K | 1.31M | 83.71% | ↗ |
| 49 | 2019 | Dell Faulkingham, Senior Vice President, Chief Commercial Officer | 297.7K | — | 111.3K | 663.6K | 169.2K | — | 1.24M | 62.40% | ↗ |
| 50 | 2019 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | 197.0K | — | 41.3K | 604.0K | 176.7K | 55.5K | 1.07M | 60.05% | ↗ |
| 51 | 2019 | David A. Spellman, Senior Vice President, Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 52 | 2018 | John P. Butler, President and Chief Executive Officer | 594.7K | — | 1.27M | 1.24M | 360.4K | 2.0K | 3.47M | 72.43% | ↗ |
| 53 | 2018 | Rita Jain, M.D., former Senior Vice President, Chief Medical Officer | 429.9K | — | 420.4K | 411.3K | 172.2K | 2.0K | 1.44M | 57.93% | ↗ |
| 54 | 2018 | Jason A. Amello, Former Senior Vice President, Chief Financial Officer and Treasurer | 380.4K | — | 278.9K | 272.6K | 157.2K | 2.0K | 1.09M | 50.54% | ↗ |
| 55 | 2018 | Jason A. Amello, Senior Vice President, Chief Financial Officer and Treasurer | 380.4K | — | 278.9K | 272.6K | 157.2K | 2.0K | 1.09M | 50.54% | ↗ |
| 56 | 2018 | Jason A. Amello Senior Vice President, Chief Financial Officer and Treasurer | 380.4K | — | 278.9K | 272.6K | 157.2K | 2.0K | 1.09M | 50.54% | ↗ |
| 57 | 2018 | Michel Dahan, Senior Vice President, Chief Operating Officer | 370.9K | — | 277.4K | 270.6K | 150.5K | 2.0K | 1.07M | 51.15% | ↗ |
| 58 | 2018 | Dell Faulkingham, Senior Vice President, Chief Commercial Officer | — | — | — | — | — | — | — | — | ↗ |
| 59 | 2018 | Steven K. Burke, M.D., Senior Vice President, Chief Medical Officer | — | — | — | — | — | — | — | — | ↗ |
| 60 | 2018 | David A. Spellman, Senior Vice President, Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 61 | 2018 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer and Corporate Secretary | — | — | — | — | — | — | — | — | ↗ |
| 62 | 2017 | John P. Butler, President and Chief Executive Officer | 542.8K | — | 1.21M | 1.37M | 277.8K | 2.0K | 3.41M | 75.87% | ↗ |
| 63 | 2017 | Rita Jain, M.D. Senior Vice President, Chief Medical Officer | 255.4K | — | — | 1.89M | 94.2K | 2.0K | 2.24M | 84.31% | ↗ |
| 64 | 2017 | Rita Jain, M.D., former Senior Vice President, Chief Medical Officer | 255.4K | — | — | 1.89M | 94.2K | 2.0K | 2.24M | 84.31% | ↗ |
| 65 | 2017 | Michel Dahan, Senior Vice President, Chief Operating Officer | 315.1K | — | 400.5K | 452.3K | 106.9K | 2.0K | 1.28M | 66.79% | ↗ |
| 66 | 2017 | Michel Dahan Senior Vice President, Chief Business Officer | 315.1K | — | 400.5K | 452.3K | 106.9K | 2.0K | 1.28M | 66.79% | ↗ |
| 67 | 2017 | Jason A. Amello, Senior Vice President, Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 68 | 2017 | Dell Faulkingham, Senior Vice President, Chief Commercial Officer | — | — | — | — | — | — | — | — | ↗ |
| 69 | 2017 | Nicole R. Hadas, Senior Vice President, Chief Legal Officer and Corporate Secretary | — | — | — | — | — | — | — | — | ↗ |
| 70 | 2015 | John P. Butler Chief Executive Officer and President | 500.0K | 257.5K | — | 1.03M | — | 2.0K | 1.79M | 57.47% | ↗ |
| 71 | 2014 | Bradley J. Maroni, M.D. | 136.9K | 44.6K | — | 2.22M | — | 495.00 | 2.40M | 92.41% | ↗ |
| 72 | 2014 | John P. Butler Chief Executive Officer and President | 425.0K | 127.3K | — | 725.9K | — | 282.00 | 1.28M | 56.78% | ↗ |
| 73 | 2014 | John P. Butler Chief Executive Officer and President | 425.0K | 127.3K | — | 725.9K | — | — | 1.28M | 56.79% | ↗ |
| 74 | 2014 | Robert Shalwitz, M.D. Former Executive Vice President and Former Chief Medical Officer | 358.9K | 122.8K | — | 337.0K | — | 88.9K | 907.6K | 37.13% | ↗ |
| 75 | 2014 | Jason A. Amello Senior Vice President, Chief Financial Officer and Treasurer | 320.0K | 95.9K | — | 337.0K | — | 251.00 | 753.1K | 44.75% | ↗ |
| 76 | 2013 | John P. Butler Chief Executive Officer and President | 124.8K | 37.2K | — | 2.13M | — | 40.00 | 2.29M | 92.92% | ↗ |
| 77 | 2013 | John P. Butler Chief Executive Officer and President | 124.8K | 37.2K | — | 2.13M | — | — | 2.29M | 92.92% | ↗ |
| 78 | 2013 | Robert Shalwitz, M.D. Former Executive Vice President and Former Chief Medical Officer | 294.1K | 59.9K | 944.0K | — | — | 25.0K | 1.32M | 71.35% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| John Butler | Chief Executive Officer, President & Director | 1M | male |
| Carolyn Rucci | Senior Vice President, Chief Legal Officer & Secretary | 933.3K | female |
| Steven Keith Burke | Senior Vice President and Chief Research & Development Officer | 860.3K | — |
| Erik John Ostrowski | Chief Business Officer, Senior Vice President, Chief Financial Officer & Treasurer | 792.9K | male |
| Nicholas Grund | Senior Vice President & Chief Commercial Officer | 728.9K | male |
| Richard C. Malabre | Senior VP & Chief Accounting Officer | — | male |
| Tracey Vetterick | Vice President of Portfolio Strategy & Corporate Administration | — | female |
| Justin McCue | Senior VP & Chief Technology Officer | — | — |
| Kimberly Garko | Senior Vice President & Chief Technical Officer | — | female |
| Mercedes Carrasco | Senior Director of Investor & Corporate Communications | — | — |
| Meredith Bowman | Senior Vice President & Chief People Officer | — | female |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for AKBA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
